数字监控的吸入疗法:一种"智能"的方式来管理严重的喘?
Dominic L Sykes1,2, Yee Yong See2, Evon C Y Chow2
1Respiratory Research Group, Hull York Medical School, Heslington, UK.
概括
智能吸入器可以改善严重喘患者的治疗坚持和喘控制,从而可能防止需要生物疗法. 这项技术提供客观的遵守监测,以获得更好的患者结果.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 数字健康数字健康
背景情况:
- 坚持治疗是治疗严重喘的一个重大挑战,特别是吸入性皮质类固醇.
- 不良的坚持与更糟糕的患者结果和增加的医疗保健成本有关.
- 客观地测量合性对于有效的喘管理至关重要.
研究的目的:
- 为了评估"智能"吸入器在严重喘患者中监测坚持的有效性.
- 为了评估智能吸入器跟踪坚持对整体喘控制的影响.
- 为了确定是否改善的坚持可以防止启动生物疗法.
主要方法:
- 77名严重喘患者被转换为使用莫梅/英达卡特罗尔/甘皮龙吸入器.
- 使用智能吸入器和螺旋健康应用程序监测了坚持,使用率>80%被定义为良好的坚持.
- 临床数据,包括FeNO和喘控制问卷 (ACQ-6) 评分,在基线和12个月收集.
主要成果:
- 65%使用智能吸入器的参与者在12个月后实现了良好的喘控制并避免了生物药物.
- 在所有参与者中观察到ACQ-6分数的显著降低,在坚持群体之间没有显著差异.
- 具有最佳粘附的患者显示中位数FeNO水平显著下降.
结论:
- 智能吸入器显示为增强坚持和改善严重喘中喘控制的工具.
- 通过智能吸入器进行客观的坚持监测可能有助于减少对昂贵的生物治疗的需求.
- 进一步的研究可以验证数字健康工具在治疗慢性呼吸道疾病中的作用.
相关概念视频
01:23Inhaled Medications
269
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
269
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:30Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
207
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
207
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298